Literature DB >> 19664529

Pathogenesis of neurologic manifestations of Mycoplasma pneumoniae infection.

Mitsuo Narita1.   

Abstract

Mycoplasma pneumoniae has been associated with various neurologic manifestations, but exactly how the organism can cause such a wide variety of diseases is a long-standing mystery. In this respect, although pneumonia has been considered the hallmark of Mycoplasma pneumoniae infection, emerging accumulations of data have revealed that the infection can cause a number of extrapulmonary manifestations even in the absence of pneumonia. The importance of host immune response in the pathomechanism of pneumonia has been established, but the pathomechanisms of extrapulmonary manifestations remain largely unknown. For this review, extrapulmonary manifestations due to M. pneumoniae infection were classified into three categories: a direct type, in which locally induced cytokines must play a role; an indirect type, in which immune modulation such as autoimmunity must play a role; and a vascular occlusion type, in which vasculitis or thrombosis (either or both, and with or without systemic hypercoagulable state) must play a role. This classification was then applied within a literature review for neurologic manifestations. Most neurologic manifestations due to M. pneumoniae infection could be reasonably classified into and explained by one of the three types of pathomechanisms.

Entities:  

Mesh:

Year:  2009        PMID: 19664529     DOI: 10.1016/j.pediatrneurol.2009.04.012

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  37 in total

Review 1.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  Implication of glycerol and phospholipid transporters in Mycoplasma pneumoniae growth and virulence.

Authors:  Stephanie Großhennig; Sebastian R Schmidl; G Schmeisky; Julia Busse; Jörg Stülke
Journal:  Infect Immun       Date:  2013-01-07       Impact factor: 3.441

3.  Combined Striatum, Brain Stem, and Optic Nerve Involvement due to Mycoplasma pneumoniae in an Ambulatory Child.

Authors:  Jin-Won Bae; Hak-Jin Kim; Gregory Youngnam Chang; Eun-Joo Kim
Journal:  Case Rep Neurol       Date:  2011-05-13

4.  Interleukin-17A Exacerbates Disease Severity in BALB/c Mice Susceptible to Lung Infection with Mycoplasma pulmonis.

Authors:  Maximillion T Mize; Xiangle L Sun; Jerry W Simecka
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

5.  Chronic meningitis with intracranial hypertension and bilateral neuroretinitis following Mycoplasma pneumoniae infection.

Authors:  Konstantinos Karampatsas; Himanshu Patel; Sheikh N Basheer; Andrew J Prendergast
Journal:  BMJ Case Rep       Date:  2014-12-23

Review 6.  Isolated optic neuritis associated with Mycoplasma pneumoniae infection: report of two cases and literature review.

Authors:  Seo-Young Choi; You-Jin Choi; Jae-Hwan Choi; Kwang-Dong Choi
Journal:  Neurol Sci       Date:  2017-03-20       Impact factor: 3.307

7.  Mycoplasma pneumoniae: Innocent Bystander or a True Cause of Central Nervous System Disease?

Authors:  Ari Bitnun; Susan E Richardson
Journal:  Curr Infect Dis Rep       Date:  2010-07       Impact factor: 3.725

8.  Characterization of the neurological diseases associated with Mycoplasma pneumoniae infection and anti-glycolipid antibodies.

Authors:  Motoi Kuwahara; Makoto Samukawa; Tae Ikeda; Miyuki Morikawa; Rino Ueno; Yukihiro Hamada; Susumu Kusunoki
Journal:  J Neurol       Date:  2016-12-26       Impact factor: 4.849

9.  Reversible splenial lesion syndrome associated with acute Mycoplasma pneumoniae-associated encephalitis: A report of four cases and literature review.

Authors:  Xiaoyu Dong; Shuyan Cong
Journal:  Exp Ther Med       Date:  2018-07-02       Impact factor: 2.447

10.  Vitamin A deficiency is associated with severe Mycoplasma pneumoniae pneumonia in children.

Authors:  Yan Xing; Kai Sheng; Xiumei Xiao; Jiawei Li; Hongling Wei; Ling Liu; Wei Zhou; Xiaomei Tong
Journal:  Ann Transl Med       Date:  2020-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.